The aim of the present study is to prospectively assess whether deep neuromuscular blockade
(NMB) (zero response to train of four and a post tetanic count of no more than 10 responses
using a nerve stimulator monitoring) until the end of surgery, followed by sugammadex
(bridion®) reversal is superior to the present practice of gradual NMB reduction at the end
of surgery followed by neostigmine (Prostigmin®, Vagostigmin®) reversal, in patients
undergoing laparoscopic sleeve gastrectomy. The investigators hypothesize that providing deep
NMB throughout the procedure creates better conditions for surgery, while reversal of deep
NMBwith sugammadex (bridion®) will enable quick and full reversal of relaxation and fewer
postoperative respiratory events as compared to neostigmine (Prostigmin®,
Vagostigmin®)reversal. Participants will be followed for the duration of hospital stay, an
expected average of 7 days.